Influence of anticancer agents on cell survival, proliferation, and CD4+CD25+Foxp3+ regulatory T cell-frequency in human peripheral-blood mononuclear cells activated by T cell-mitogen

International Immunopharmacology

Volumn 15, Issue 1, 2013, Pages 160-166

  Tohyama, Naoya ^a   Tanaka, Sachiko ^a   Onda, Kenji ^a   Sugiyama, Kentaro ^a   Hirano, Toshihiko ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

Anticancer agents; CD4+CD25 +Foxp3+ regulatory T cells; Cytokine; Peripheral blood mononuclear cells; T cell mitogen

Indexed keywords

ARSENIC TRIOXIDE; CONCANAVALIN A; DACARBAZINE; FLUOROURACIL; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; METHOTREXATE; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL ACTIVATION; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; IMMUNITY; IN VITRO STUDY; LYMPHOCYTE FUNCTION; MALE; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; ARSENICALS; CELL PROLIFERATION; CELL SURVIVAL; CONCANAVALIN A; CYTOKINES; DACARBAZINE; FEMALE; FLUOROURACIL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKOCYTES, MONONUCLEAR; MALE; METHOTREXATE; MITOGENS; OXIDES; T-LYMPHOCYTES, REGULATORY; YOUNG ADULT;

EID: 84871365589     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2012.11.008     Document Type: Article

References (27)

1. W. Adachi, A. Sugenoya, N. Horigome, C. Takahashi, F. Iida, and J. Nakayama The antitumor activity and immunosuppressive effects of 5-fluorouracil suppositories in rectal cancer patients Surg Today 22 3 1992 221 225
2. S.A. Grossman, X. Ye, G. Lesser, A. Sloan, H. Carraway, and S. Desideri NABTT CNS Consortium. Immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide Clin Cancer Res 17 16 2011 5473 5480
3. X. Gao, Y. Zhu, G. Li, H. Huang, G. Zhang, and F. Wang TIM-3 expression characterizes regulatory T cells in tumor tissues and is associated with lung cancer progression PLoS One 7 2 2012 e30676
4. L. Weiss, T. Melchardt, A. Egle, C. Grabmer, R. Greil, and I. Tinhofer Regulatory T cells predict the time to initial treatment in early stage chronic lymphocytic leukemia Cancer 117 10 2011 2163 2169
5. R.A. Peterson Regulatory T-cells: diverse phenotypes integral to immune homeostasis and suppression Toxicol Pathol 40 2 2012 186 204
6. V. Sisirak, J. Faget, M. Gobert, N. Goutagny, N. Vey, and I. Treilleux Impaired IFN-a production by plasmacytoid dendritic cells favors regulatory T cell expansion and contributes to breast cancer progression Cancer Res 72 20 Jul 25 2012 1 10
7. A. Facciabene, G.T. Motz, and G. Coukos T-regulatory cells: key players in tumor immune escape and angiogenesis Cancer Res 72 9 2012 2162 2171
8. T. Hirano Cellular pharmacodynamics of immunosuppressive drugs for individualized medicine Int Immunopharmacol 7 2007 3 22
9. K. Sugiyama, K. Isogai, S. Horisawa, A. Toyama, H. Satoh, and K. Saito Comparative study of the cellular pharmacodynamics of tacrolimus in renal transplant recipients treated with and without basiliximab Cell Transplant 21 2012 565 570
10. T. Hirano, H. Fukushima, Y. Sasaki, N. Yoshikawa, M. Yoshida, and K. Oka Bacterial Superantigen TSST-1 attenuates suppressive efficacy of glucocorticoids and calcineurin inhibitors against blastogenesis of peripheral blood mononuclear cells from patients with antineutrophil cytoplasmic antibody-associated vasculitis and nephrosis Int Immunopharmacol 6 2006 924 934
11. M. Masuda, M. Matsumoto, S. Tanaka, K. Nakajima, N. Yamada, and N. Ido Clinical implication of peripheral CD4(+)CD25(+) regulatory T cells and Th17 cells in myasthenia gravis patients J Neuroimmunol 225 2010 123 131
12. S. Kamogawa, K. Kagami, M. Maeda, K. Arai, Y. Okubo, and R. Tsuboi Suppressive efficacies of roxithromycin against human peripheral-blood mononuclear cells stimulated with hemolytic streptococci superantigen Eur J Pharmacol 602 2009 439 447
13. S. Mukherjee, C. Giamberardino, J.M. Thomas, K. Gowdy, A.M. Pastva, and J.R. Wright Surfactant protein A modulates induction of regulatory T cells via TGF-β J Immunol 188 9 2012 4376 4384
14. X.-M. Hu, T. Hirano, and K. Oka Arsenic trioxide induces apoptosis in MOLT-4 and its daunorubicin-resistant MOLT-4 cell lines via depletion of intracellular glutathione, disruption of mitochondrial membrane potential and activation of caspase-3 Cancer Chemother Pharmacol 52 2003 47 58
15. W.J. Hwu, and D.E. Mozdziesz Molecular basis for thymidine modulation of the efficacy and toxicity of alkylating agents Pharmacol Ther 76 1-3 1997 101 116
16. K. Koprowska, and M. Czyż Dacarbazine, a chemotherapeutic against metastatic melanoma and a reference drug for new treatment modalities Postepy Hig Med Dosw (Online) 65 2011 734 751
17. P. Álvarez, J.A. Marchal, H. Boulaiz, E. Carrillo, C. Vélez, and F. Rodríguez-Serrano 5-Fluorouracil derivatives: a patent review Expert Opin Ther Pat 22 2 2012 107 123
18. J.J. McGuire Anticancer antifolates: current status and future directions Curr Pharm Des 9 31 2003 2593 2613
19. M. Collinge, S.H. Cole, P.A. Schneider, C.B. Donovan, C. Kamperschroer, and T.T. Kawabata Human lymphocyte activation assay: an in vitro method for predictive immunotoxicity testing J Immunotoxicol 7 4 2010 357 366
20. N. Haroon, R. Srivastava, R. Misra, and A. Aggarwal A novel predictor of clinical response to methotrexate in patients with rheumatoid arthritis: a pilot study of in vitro T cell cytokine suppression J Rheumatol 35 6 2008 975 978
21. C.G. Jackson, and H.J. Williams Disease-modifying antirheumatic drugs. Using their clinical pharmacological effects as a guide to their selection Drugs 56 3 1998 337 344
22. E. Brazowski, K. Eytan, and A. Eisenthal In vitro modulation of interleukin-2-mediated human peripheral mononuclear cell proliferation and antitumor cytotoxicity by 5-fluorouracil Anticancer Res 27 6B 2007 4135 4141
23. K. Maeda, S. Hazama, K. Tokuno, S. Kan, Y. Maeda, and Y. Watanabe Impact of chemotherapy for colorectal cancer on regulatory T-cells and tumor immunity Anticancer Res 31 12 2011 4569 4574
24. C.E. Fadul, J.L. Fisher, J. Gui, T.H. Hampton, A.L. Côté, and M.S. Ernstoff Immune modulation effects of concomitant temozolomide and radiation therapy on peripheral blood mononuclear cells in patients with glioblastoma multiforme Neuro Oncol 13 4 2011 393 400
25. R.K. Samstein, A. Arvey, S.Z. Josefowicz, A. Reynolds, R. Sandstrom, and S. Neph Foxp3 exploits a pre-existent enhancer landscape for regulatory T cell lineage specification Cell 151 1 2012 153 166
26. T. Maruyama, K. Kono, Y. Mizukami, Y. Kawaguchi, K. Mimura, and M. Watanabe Distribution of Th17 cells and FoxP3(+) regulatory T cells in tumor-infiltrating lymphocytes, tumor-draining lymph nodes and peripheral blood lymphocytes in patients with gastric cancer Cancer Sci 101 9 2010 1947 1954
27. M. Pyzik, and C.A. Piccirillo The TGF-beta1/Foxp3 regulatory axis in immune self-tolerance: implications for health and disease Inflamm Allergy Drug Targets 5 3 2006 167 177